Imaging services provider Diagnostic Health Services of Dallasannounced last week that it has signed an agreement to buy fourhospital-based MRI operations run by Diagnostic Imaging Servicesof Los Angeles. DHS also announced that it has acquired
Imaging services provider Diagnostic Health Services of Dallasannounced last week that it has signed an agreement to buy fourhospital-based MRI operations run by Diagnostic Imaging Servicesof Los Angeles. DHS also announced that it has acquired UltrasoundDiagnostic Services, a Phoenix-based provider of ultrasound services.
Diagnostic Imaging Services is owned by Primedex Health Systems,which also operates imaging center chain RadNet and managed-serviceorganization Future Diagnostics. Primedex said in September thatit was "exploring strategic options" for the company,and the Diagnostic Health sale apparently fits that intention(SCAN 10/9/96).
The four MRI operations that Diagnostic Health is buying arebased in southern California and are situated on the grounds ofhospitals, which fits the business model that DHS follows, accordingto chairman and CEO Max Batzer.
"We are not in the freestanding center market,"Batzer said. "Our model is department management. This givesus a chance to enter the department through MRI rather than throughour traditional power alleys of ultrasound and nuclear medicine."
The California operations will also complement Diagnostic Health'sactivity in Nevada and Arizona, the company said. The DIS andUDI acquisitions are expected to add $12 million in annual revenuesto DHS. The UDI deal is complete, while the DIS purchase is expectedto close by March 31. DHS paid $1.1 million in cash and stockfor UDI, but terms of the DIS deal were not disclosed.
Primedex executives declined to comment on whether they willcontinue to divest parts of their company.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.